FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/08/056302 [Registered on: 09/08/2023] Trial Registered Prospectively
Last Modified On: 08/08/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparing and evaluating the pain perception and wound healing effectiveness of 2 different medications Triphala Guggulu or Ketrolac tromethamine after periodontal flap surgery. 
Scientific Title of Study   Analgesic, anti-inflammatory and wound healing efficacy of Triphala Guggulu and Ketrolac tromethamine after periodontal flap surgery -A randomized double-blind clinical trial  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Alsha Thankam George 
Designation  I MDS 
Affiliation  KVG Dental College and Hospital  
Address  KVG Dental College and Hospital, Dakshina Kannada, Sullia,

Dakshina Kannada
KARNATAKA
574327
India 
Phone  8078337581  
Fax    
Email  dralshageorge@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shivananda H 
Designation  Reader 
Affiliation  KVG Dental College and Hopsital  
Address  KVG Dental College & Hospital, Dakshina Kannada , Sullia

Dakshina Kannada
KARNATAKA
574327
India 
Phone  08078337581  
Fax    
Email  Shivanand_perio@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Alsha George 
Designation  I MDS 
Affiliation  KVG DENTAL COLLEGE AND HOSPITAL  
Address  KVG Dental College and Hospital, Dakshina Kannada, Sullia

Dakshina Kannada
KARNATAKA
574327
India 
Phone  08078337581  
Fax    
Email  dralshageorge@gmail.com  
 
Source of Monetary or Material Support  
KVG Dental College and Hospital, Dakshina Kannada,Sullia  
 
Primary Sponsor  
Name  Dr Alsha Thankam George 
Address  KVG Dental College and Hospital, Dakshina Kannada , Sullia 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Alsha   KVG Dental College and Hospital  Department of Periodontology Room no 11,Kurunjibhag,Sullia,574327
Dakshina Kannada
KARNATAKA 
8078337581

dralshageorge@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee ,KVG Dental College and Hospital   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K053||Chronic periodontitis. Ayurveda Condition: UPAKUSAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: TRIPHALA GUGGULU, Reference: SARANGADHARA MADHYAMA KHANDA, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1000(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 1 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator Arm (Non Ayurveda)-KETROLAC TROMETHAMINE KETOROLAC TROMETHAMINE is a nonsteroidal anti-inflammatory analgesics drugs NSAIDs)used in dental treatment.
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Maintenance of good oral hygiene after phase 1 therapy.
2.age ranging from 30 years to 65 years.
3.patients who are systemically healthy.
4.patients who are willing to participate in this study.
5.probings pocket depth >5mm or clinical attachment >3mm in atleast 3 teeth in more than one sextant after phase one therapy. 
 
ExclusionCriteria 
Details  1.The patients who are undergoing treatment with analgesics or corticosteroids during the trial period.
2.patients with history or clinical evidence of allergy to ketorolac tromethamine and Triphala guggulu.
3.pregnancy and lactating mothers.
4. smokers and alcoholics. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
The primary outcome is to measure the mean post-operative pain using visual analog scale   After periodontal flap surgery, visual analog scale will be measured immediately after surgery, hourly intervals from 1 to 8 hours on the day of
surgery and 2 times (morning and night) on the 2
and 3rd postoperative days.
 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the postoperative tissue response & wound healing after periodontal flap surgery   Tissue response, which is tissue edema, tissue color (TC), & wound healing will be assessed after 1 week postoperatively  
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   18/08/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   All the patients will be selected from the outpatient section of the Department of Periodontology, KVG Dental College and Hospital, Sullia. 20 subjects diagnosed with periodontitis undergoing periodontal flap surgeries will be selected for the study. Sextants are selected randomly and divided into 2 groups, Group A and Group B.
Group A will be given 2 tabs Triphala Guggulu 500mg, 30 mins before the administration of local anesthesia and group B will be given 1 tab ketorolac tromethamine 10mg,30 mins before the administration of local anesthesia. 
The subjects in Group A will be given 2 tabs of Triphala Guggulu 500mg and Group B 1 tab of ketorolac tromethamine 10mg after 8 hours from the completion of the surgical procedure. After the surgery, a customized chart will be provided to the subject, to self-report postoperative pain using a visual analog scale (VAS).
VAS will be measured immediately after surgery, hourly intervals from 1 to 8 hours on the day of surgery and 2 times (morning and night) on the 2 and 3rd postoperative days. 
The following parameters will be assessed-
1. Tissue response - Based on Sanz-Moliner JD et al,2013 visual analysis
2. The early wound healing scale Based on Landry et al
Statistical analysis will be performed to compare the changes in clinical parameters between Group A and Group B
Prior to the surgical procedure, all participants will have an examination and treatment planning appointment and will receive oral hygiene instructions as well as initial scaling and root planing treatment. Flap surgery will be conducted under the standard protocol. 
The patients will be recalled after one week postoperatively for suture removal and assessment of clinical parameters.

SURGICAL PROCEDURE 
Subjects that meet the inclusion criteria will be chosen for flap surgery. Preoperatively patients will be given chlorhexidine mouthwash 0.12%(perioguard)for mouth rinsing before giving local anesthesia. All aseptic precautions and standard protocol will be followed during flap surgery. Group A will be given 2 tabs Triphala guggulu 500mg (PATANJALI) 30 mins before the administration of local anesthesia and group B will be given 1tab ketorolac tromethamine 10mg (KetorolTM-DT) 30 mins before the administration of local anesthesia All the patients will be treated using 2%lignocaine hydrochloride with adrenaline in 1:80000 concentrations (Lignox2%-A). Incisions will be placed with B.P blade no 15 on the buccal and lingual surface and B.P no 12 on the interdental region. Following reflection and debridement, the surgical site will be irrigated and flap approximation will be using 4-0  silk suture and covered with a periodontal dressing(coe-pack). 
Post-operative instruction will be given. 
The subjects in Group A will be given 2 tabs of Triphala Guggulu 500mg and Group B 1 tab of ketorolac tromethamine 10mg after 8 hours from the completion of the surgical procedure. The patients will be recalled after one week postoperatively for suture removal and assessment of clinical parameters.

POST-OPERATIVE RECALL 
Subjects will be reviewed after the 7th day for evaluation of clinical parameters.
A customized chart will be provided to the subject, to self-report postoperative pain using a visual analog scale (VAS) . VAS will be measured immediately after surgery, hourly intervals from 1 to 8 hours on the day of surgery and 2 times (morning and night) on the 2nd and 3rd postoperative days. 
 
Close